An interventional study of gamified motor rehabilitation and conventional physical therapy treatment for patient with carpal tunnel syndrome in Carpal Tunnel Surgery, sponsored by Al-Zaytoonah University of Jordan. Not yet recruiting. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Al-Zaytoonah University of Jordan · Not applicable, Interventional, and Treatment
Carpal tunnel syndrome is the most common peripheral entrapment neuropathy and may result in sensory and motor impairment, particularly in patients with severe disease and thenar muscle atrophy. Progressive gamified motor rehabilitation using sensor-based interactive technology may provide an engaging approach to facilitate repetitive, task-oriented hand and thumb movements while allowing progression according to the individual's performance and tolerance. However, the effectiveness of incorporating such an approach into conventional postoperative rehabilitation in patients with severe carpal tunnel syndrome and thenar atrophy remains unclear.
Al-Zaytoonah University of Jordan is the lead sponsor of 31 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
received gamified motor rehabilitation and conventional treatment
Other: gamified motor rehabilitation
received conventional treatment (hand grip strengthening exercise functional care training)
Other: conventional physical therapy treatment for patient with carpal tunnel syndrome
uses interactive smartphone apps connected with small ball via Bluetooth to turn standard hand and thumb exercises into engaging, game-like tasks.
* Nerve Gliding (Neurodynamic) Exercises: Gentle movements of the wrist, fingers, and head help the median nerve slide smoothly through the carpal tunnel and prevent it from sticking to surrounding tissues. * Tendon Gliding Exercises: Specific finger and hand sequences (such as moving from a straight hand to a hook, full fist, and tabletop position) encourage smooth tendon movement and decrease swelling. * Stretching \& Strengthening: Gentle flexor and extensor stretches improve flexibility, while progressive strengthening exercises for the hand, wrist, and forearm are introduced once acute symptoms subside.
Median Nerve Motor Distal Latency and Motor Conduction Velocity
Median nerve motor distal latency (DL), measured in milliseconds (ms), and motor conduction velocity (MCV), measured in meters per second (m/s), will be assessed using a nerve conduction study before and after the intervention to evaluate motor nerve conduction following carpal tunnel release.
Time frame: 6 weeks
Arabic Version of the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) Questionnaire
Upper-limb disability and symptoms will be assessed using the Arabic version of the QuickDASH questionnaire, an 11-item patient-reported outcome measure. The total score ranges from 0 to 100, with higher scores indicating greater disability. The questionnaire will be administered at baseline and immediately after the intervention to assess changes in upper-limb functional status.
Time frame: 6 weeks
Arabic Version of the Boston Carpal Tunnel Questionnaire (BCTQ) Score
Carpal tunnel syndrome symptoms and functional limitations will be assessed using the Arabic version of the Boston Carpal Tunnel Questionnaire (BCTQ), a patient-reported outcome measure consisting of two subscales: the Symptom Severity Scale (SSS; 11 items) and the Functional Status Scale (FSS; 8 items). Each item is scored on a 1-5 scale, with higher scores indicating greater symptom severity and functional limitation. The questionnaire will be administered at baseline and immediately after the intervention.
Time frame: 6 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al-Zaytoonah University of Jordan